Ticker brief
NVAX NOVAVAX INC
Consumer, Non-cyclical · Biotechnology
last close
$9.70
1 day
-2.9%
14 days
-23.9%
mkt cap
$1.6B
signals 14d
110
authors 14d
55
crowd 14d
+0.5σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 103% rich · 94 pctile own 1y | IV/HV 1.10× |
| Skew — 25Δ RR 30d | +0.075 47 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +1.26 thin | 5-session Δ -1.47 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-05-20 (z=5.2) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-15 · now +0.28 (−1 bearish … +1 bullish)
Who spoke55
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TheBronxViking | C | -2.43 | 14 | +0.46 |
| @Tautilas | C | -0.32 | 6 | +0.58 |
| @MWM76 | C | +3.16 | 6 | +0.29 |
| @OptionsFlowBoss | C | · | 6 | +0.35 |
| @Greatstockpix | C | -1.40 | 5 | +0.28 |
| @42traders | B | -1.22 | 5 | +0.39 |
| @DanzTrader | C | -3.33 | 4 | +0.50 |
| @Brad_E_Schulz | C | · | 4 | +0.31 |
| @BearaBullBella | C | -2.84 | 3 | +0.40 |
| @Tradingchannels | C | -0.02 | 3 | +0.50 |
| @CHItrader | B | -0.22 | 3 | +0.15 |
| @StockPatternPro | C | -0.75 | 2 | +0.52 |
| @LeaderInvests | C | -3.64 | 2 | -0.02 |
| @GetPursa | C | +0.10 | 2 | +0.15 |
| @AnthonySandford | C | · | 2 | +0.00 |
| @TheNewMoney_app | C | · | 2 | +0.58 |
| @bullishchart | C | -1.21 | 2 | +0.17 |
| @DustinHuntwn | C | -3.75 | 2 | +0.78 |
| @AlertsAndNews | C | -3.92 | 1 | +0.35 |
| @RichardWedekin1 | B | +1.09 | 1 | -0.50 |
| @TLAMB91 | C | -0.14 | 1 | +0.10 |
| @Blair519 | C | +0.23 | 1 | +0.55 |
| @UTEX_io | C | +0.04 | 1 | +0.25 |
| @HiddenPivots | C | +1.39 | 1 | +0.65 |
| @DilBradly | B | -0.88 | 1 | +0.45 |
Recent signals30of 110 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @TheBronxViking | +0.60 | Brief enthusiastic reaction signals bullish sentiment toward NVAX, supported by linked flow context. | -24.3% | tweet ↗ |
| 2026-10-15 | @kiantrades | +0.25 | Flags NVAX call flow, with the media needed for contract details. | -24.3% | tweet ↗ |
| 2026-10-15 | @TradeIdeasLLC | +0.00 | Daily swing-setup watchlist with price alerts but no concrete entry intent. | -24.3% | tweet ↗ |
| 2026-10-14 | @DanzTrader | +0.50 | Identifies $13.40 as resistance that must clear for a move to $14 or higher. | -23.3% | tweet ↗ |
| 2026-10-13 | @Greatstockpix | +0.00 | Publishes an October 14 day-trading watchlist without standalone entries or directional levels. | -24.3% | tweet ↗ |
| 2026-10-13 | @BearaBullBella | +0.00 | References an unexplained NVAX level of 15. | -24.3% | tweet ↗ |
| 2026-10-13 | @Greatstockpix | +0.55 | Says NVAX looks good at the current chart setup. | -24.3% | tweet ↗ |
| 2026-10-12 | @FluxCharts | +0.65 | NVAX broke resistance with bullish momentum and holds near $12.75. | -23.4% | tweet ↗ |
| 2026-10-12 | @USAnt_IDEA | +0.35 | Links Moderna's 600% rally to cancer-vaccine news, index inclusion and sector-wide momentum, while noting trial risk. | -23.4% | tweet ↗ |
| 2026-10-12 | @TradetheMatrix1 | +0.55 | Sees multi-day or multi-week upside potential if plague news persists. | -23.4% | tweet ↗ |
| 2026-10-12 | @DanzTrader | +0.80 | Calls a two-year NVAX base breakout with potential for an MRNA-like move. | -23.4% | tweet ↗ |
| 2026-10-12 | @oratnek_ill | +0.10 | Daily watchlist ranks technical setups and breakout health across multiple stocks. | -23.4% | tweet ↗ |
| 2026-10-11 | @Greatstockpix | +0.00 | Publishes an October 12 day-trading watch list; only the first six tickers are retained. | -23.9% | tweet ↗ |
| 2026-10-11 | @kkernttb | +0.20 | Names a ranked list of favorable technical setups without entry intent. | -23.9% | tweet ↗ |
| 2026-10-10 | @SteveDJacobs | +0.20 | Lists stocks passing a Minervini trend-template scan. | -23.9% | tweet ↗ |
| 2026-10-10 | @VistaPResearch | +0.40 | Reports rallies in Moderna and Novavax tied to cancer-vaccine investor confidence. | -23.9% | tweet ↗ |
| 2026-10-10 | @DustinHuntwn | +0.75 | Bullish thesis centers on Sanofi's combination vaccine and future milestones and royalties. | -23.9% | tweet ↗ |
| 2026-10-10 | @DustinHuntwn | +0.80 | Uses BE's past 1,655% gain as an analogy for NVAX and other early-stage biotech opportunities. | -23.9% | tweet ↗ |
| 2026-10-10 | @artinmemes | +0.30 | Presents a U.S.-stock basket that could benefit from rising concern about plague in Russia. | -23.9% | tweet ↗ |
| 2026-10-10 | @thesetupfactory | +0.40 | Discloses ownership of NTAP and SNOW while presenting six stocks with bullish relative-strength signals. | -23.9% | tweet ↗ |
| 2026-10-10 | @bullishchart | +0.45 | Novavax may receive up to $350M in vaccine milestones while shares show a bullish technical cross. | -23.9% | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.50 | Lists watched stocks gaining at least 4% on at least 1.5 times average volume. | -23.9% | tweet ↗ |
| 2026-10-09 | @equitydd | +0.20 | Lists the day's large gainers; ticker extraction is capped at six. | -23.9% | tweet ↗ |
| 2026-10-09 | @MartyChargin | +0.35 | NYT reports cancer vaccines could receive accelerated NIH treatment. | -23.9% | tweet ↗ |
| 2026-10-09 | @Greatstockpix | +0.45 | Recaps two pullback entries taken earlier today. | -23.9% | tweet ↗ |
| 2026-10-09 | @Tautilas | +0.55 | Regrets selling three positions before sizable subsequent gains. | -23.9% | tweet ↗ |
| 2026-10-09 | @DanzTrader | +0.65 | Expresses a bullish near-term expectation for NVAX above $13 | -23.9% | tweet ↗ |
| 2026-10-09 | @TheBronxViking | +0.75 | Expects a large NVAX run after a volume-backed breakout, conditional on healthcare strength. | -23.9% | tweet ↗ |
| 2026-10-09 | @42traders | +0.45 | Celebrates a strong past run across holdings in a new long-term portfolio. | -23.9% | tweet ↗ |
| 2026-10-09 | @Tradingchannels | +0.65 | Positively highlights NVAX bouncing from a broken bull-flag level. | -23.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.